XML 60 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
2014 Equity Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Stock Options Outstanding, Beginning Balance 5,203,529 3,327,140
Number of Stock Options, Granted [1] 1,595,000 1,925,000
Number of Stock Option, Exercised
Number of Stock Option, Forfeited (48,611)
Number of Stock Options Outstanding, Ending Balance 6,798,529 5,203,529
Number of Stock Options Vested and exercisable stock options 4,861,433 3,270,487
Weighted Average Exercise Price, Beginning Balance $ 2.58 $ 3.68
Weighted Average Exercise Price, Granted [1] 2.13 1.00
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited 5.00
Weighted Average Exercise Price, Ending Balance 2.55 2.58
Weighted Average Exercise Price, Vested and exercisable stock options $ 2.88 $ 3.45
Remaining Contractual Term (Years) stock options, Beginning 8 years 1 month 6 days 8 years 3 months 19 days
Remaining Contractual Term (Years) stock options, Ending Balance 7 years 3 months 19 days 8 years 1 month 6 days
Remaining Contractual Term (Years), Vested and exercisable stock options 6 years 8 months 12 days 7 years 6 months
Intrinsic Value of Outstanding Stock Option [2] $ 2,558 $ 394
Intrinsic Value of Vested and Exercisable Stock Option [2] $ 1,707 $ 126
2018 Stock Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Stock Options Outstanding, Beginning Balance 995,000 375,000
Number of Stock Options, Granted 620,000
Number of Stock Option, Exercised (3,333)
Number of Stock Option, Forfeited
Number of Stock Options Outstanding, Ending Balance 991,667 995,000
Number of Stock Options Vested and exercisable stock options 772,491  
Weighted Average Exercise Price, Beginning Balance $ 0.86 $ 0.60
Weighted Average Exercise Price, Granted 1.02
Weighted Average Exercise Price, Exercised 1.50
Weighted Average Exercise Price, Forfeited
Weighted Average Exercise Price, Ending Balance 0.86 $ 0.86
Weighted Average Exercise Price, Vested and exercisable stock options $ 0.83  
Remaining Contractual Term (Years) stock options, Beginning 9 years 9 years 4 months 24 days
Remaining Contractual Term (Years) stock options, Ending Balance 8 years 9 years
Remaining Contractual Term (Years), Vested and exercisable stock options 7 years 10 months 25 days  
[1] Stock options granted under the PAVmed Inc. 2014 Equity Plan vest ratably over twelve quarters generally commencing with the grant date quarter and have a ten year contractual term from date-of-grant.
[2] The intrinsic value is computed as the difference between the quoted price of the PAVmed Inc. common stock on each of December 31, 2020 and 2019 and the exercise price of the underlying PAVmed Inc. stock options, to the extent such quoted price is greater than the exercise price.